Cube Labs S.P.A. (IT:CUBE) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cube Labs’ subsidiary, Adamas Biotech, has secured official registration from Italy’s Ministry of Health for Theakine® Prost, a green tea-based supplement aimed at improving prostate health. The company plans to partner with firms in the urology sector for its distribution, rather than marketing it directly. This development signifies a strategic advancement in Cube Labs’ commercial endeavors within the healthcare sector.
For further insights into IT:CUBE stock, check out TipRanks’ Stock Analysis page.